Responses
ABN abstracts 2015 ABN Annual Meeting, 10 September 2015, Institute of Education, London
Wed 20, Parallel session 4: Disease pathophysiology
027
PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY
Compose a Response to This Article
Other responses
No responses have been published for this article.